Clinical Trial Update: Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety and tolerability of inhaled nitric oxide in cystic fibrosis patients; study completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: Mallinckrodt | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-12-01